Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 6
2016 5
2017 5
2018 10
2019 5
2020 6
2021 11
2022 10
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Among authors: vanneste bgl. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial.
Staal FHE, Siang KNW, Brouwer CL, Janssen J, Budiharto TCG, Haverkort DMAD, Hollmann B, Jacobs I, De Jong MAA, van de Sande MAE, Vanneste BGL, De Jong IJ, Verzijlbergen JF, Langendijk JA, Smeenk RJ, Aluwini S. Staal FHE, et al. Among authors: vanneste bgl. Adv Radiat Oncol. 2023 Sep 17;9(2):101379. doi: 10.1016/j.adro.2023.101379. eCollection 2024 Feb. Adv Radiat Oncol. 2023. PMID: 38405312 Free PMC article.
Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Meijer D, van Leeuwen PJ, Eppinga WSC, Vanneste BGL, Meijnen P, Daniels LA, van den Bergh RCN, Lont AP, Bodar YJL, Ettema RH, de Bie KCC, Oudshoorn FHK, Nieuwenhuijzen JA, van der Poel HG, Donswijk ML, Heymans MW, Oprea-Lager DE, Schaake EE, Vis AN. Meijer D, et al. Among authors: vanneste bgl. Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar. Eur Urol Open Sci. 2024. PMID: 38384437 Free PMC article.
Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types.
Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, Dennis J, Lobato-Busto R, Alsner J, Ness A, Nutting C, Gómez-Caamaño A, Eriksen JG, Thomas SJ, Bates AM, Webb AJ, Choudhury A, Rosenstein BS, Taboada-Valladares B, Herskind C, Azria D, Dearnaley DP, de Ruysscher D, Sperk E, Hall E, Stobart H, Chang-Claude J, De Ruyck K, Veldeman L, Altabas M, De Santis MC, Farcy-Jacquet MP, Veldwijk MR, Sydes MR, Parliament M, Usmani N, Burnet NG, Seibold P, Symonds RP, Elliott RM, Bultijnck R, Gutiérrez-Enríquez S, Mollà M, Gulliford SL, Green S, Rancati T, Reyes V, Carballo A, Peleteiro P, Sosa-Fajardo P, Parker C, Fonteyne V, Johnson K, Lambrecht M, Vanneste B, Valdagni R, Giraldo A, Ramos M, Diergaarde B, Liu G, Leal SM, Chua MLK, Pring M, Overgaard J, Cascallar-Caneda LM, Duprez F, Talbot CJ, Barnett GC, Dunning AM, Vega A, Andreassen CN, Langendijk JA, West CML, Alizadeh BZ, Kerns SL; Radiogenomics Consortium. Naderi E, et al. Among authors: vanneste b. JNCI Cancer Spectr. 2023 Oct 31;7(6):pkad088. doi: 10.1093/jncics/pkad088. JNCI Cancer Spectr. 2023. PMID: 37862240 Free PMC article.
Radiotherapy Use in Muscle-Invasive Bladder Cancer: Review of the Guidelines and Impact of Increased Awareness in Patient Referral at a Tertiary Center in Belgium.
Verghote F, Van Praet C, De Maeseneer D, Berquin C, Vanneste B, De Visschere P, Verbeke SLJ, Fonteyne V. Verghote F, et al. Among authors: vanneste b. Cancer Manag Res. 2023 Jun 14;15:511-521. doi: 10.2147/CMAR.S407031. eCollection 2023. Cancer Manag Res. 2023. PMID: 37337479 Free PMC article.
A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer.
Hasannejadasl H, Osong B, Bermejo I, van der Poel H, Vanneste B, van Roermund J, Aben K, Zhang Z, Kiemeney L, Van Oort I, Verwey R, Hochstenbach L, Bloemen E, Dekker A, Fijten RRR. Hasannejadasl H, et al. Among authors: vanneste b. Front Oncol. 2023 Apr 12;13:1168219. doi: 10.3389/fonc.2023.1168219. eCollection 2023. Front Oncol. 2023. PMID: 37124522 Free PMC article.
Systematic review and meta-analysis of prediction models used in cervical cancer.
Jha AK, Mithun S, Sherkhane UB, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L. Jha AK, et al. Among authors: vanneste b. Artif Intell Med. 2023 May;139:102549. doi: 10.1016/j.artmed.2023.102549. Epub 2023 Apr 11. Artif Intell Med. 2023. PMID: 37100501 Free article. Review.
Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study.
Corkum MT, Buyyounouski MK, Chang AJ, Chung HT, Chung P, Cox BW, Crook JM, Davis BJ, Frank SJ, Henriquez I, Horwitz EM, Hoskin P, Hsu IC, Keyes M, King MT, Kollmeier MA, Krauss DJ, Kukielka AM, Morton G, Orio PF 3rd, Pieters BR, Potters L, Rossi PJ, Showalter TN, Solanki AA, Song D, Vanneste B, Vigneault E, Wojcieszek PA, Zelefsky MJ, Kamrava M. Corkum MT, et al. Among authors: vanneste b. Radiother Oncol. 2023 Jul;184:109672. doi: 10.1016/j.radonc.2023.109672. Epub 2023 Apr 13. Radiother Oncol. 2023. PMID: 37059334
68 results